TrialDiabetes, obesity & metabolism2022

Mechanisms of action of the sodium-glucose cotransporter-2 (SGLT2) inhibitor canagliflozin on tubular inflammation and damage: A post hoc mediation analysis of the CANVAS trial.

Taha Sen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.